3D Printed Drug Delivery System Shows Promise in Countering Transplant Rejection

Formnext Germany

Share this Article

i5There has been rapid progression seen in the technology used to 3D print live human cells. Over the last four to five years alone we have seen the technology go from only a concept to having several valuable applications. In fact Organovo is already selling 3D printed human liver tissue to the pharmaceutical industry for drug toxicity testing, with their ultimate goal being the 3D printing of entire human organs for transplant.

The advent of 3D printed organs would equate to tens of thousands of lives being saved, without relying on organ donors. Although we are still likely a decade or even more away from such procedures, organ transplantation is being attacked on another front as well, which is utilizing 3D printing.

Every year, thousands of individuals pass away or suffer major complications after undergoing a transplant. Whether it’s an organ or another part of the human body that’s being transplanted, the human immune system can oftentimes be a patient’s worst enemy. While a strong immune system protects us from disease, viruses, and bacteria, it also will attack any foreign body within the body, namely transplanted cells. Because of this, those who have received a transplant require immunosuppression therapy, which oftentimes can be extremely rough on the body.

i2

Researchers at Pohang University of Science and Technology (POSTECH) in South Korea believe they may have found a 3D printable solution that could increase the efficiency of immunosuppressive drugs such as cyclosporine A (CsA), while also ensuring that the drugs are delivered locally only, resulting in much fewer side effects.

“Our objective was to show the feasibility of using a subcutaneous 3D printed drug delivery system to achieve local and sustained CsA release and to investigate the local immunosuppressive effects of the CsA after cell transplantation,” said Dong-Woo Cho from POSTECH. “The improved load-bearing capacity of the combined microsphere and hydrogel system, and its ability to maintain its integrity and shape during the implantation period, helped to deliver a sustained CsA release, preventing the acceleration of the secretion of cytokines related to immune rejection.”i3

Currently the system has performed quite well in tests using animal models, outperforming previous tests for delivering drugs via microspheres (tiny biodegradable drug capsules) or hydrogels. During these tests, the microspheres usually ended up migrating from the local site requiring the medication to surrounding organs, causing potentially harmful damage.

“This research could be a fundamental study for overcoming existing cell transplantation limitations, mainly caused by systemic immuno-suppression,” wrote the researchers. “The benefit of the new 3D printed carrier system is that it provides local rather than systemic drug delivery. The carrier we developed could be a promising solution to treating several diseases that require cell-based therapy, such as muscular dystrophy, degenerative disc disease or myocardial infarction.”

It will be interesting to see how far and how quickly this research progresses, as there is a substantial window of use for such a system, at least prior to 3D printed, stem cell-spawned organs becoming readily available.

Let’s hear your thoughts on this research in the 3D Printed Drug Delivering System forum thread on 3DPB.com.



Share this Article


Recent News

Analysis: TRUMPF Sells Additive Manufacturing Business to LEO III Fund

New Frontier Aerospace Wields Mjölnir, a 3D Printed Engine for Hypersonic Flight



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

Metal Powder Supplier Elementum 3D Added to $46B Air Force Contract

Elementum 3D, a Colorado-based developer and supplier of metal powders used in additive manufacturing (AM), announced that the company has been added to the vendors list in the fourth on-ramp...

Ursa Major Lands $28.6M AFRL Deal for 3D Printed Draper Engine Flight Demo

The US Air Force Research Laboratory’s (AFRL’s) Rocket Propulsion Division at Edwards Air Force Base has awarded a $28.6 million contract to Ursa Major for follow-on work related to the...

3D Printing Financials: Rocket Lab’s Record-Breaking Year and Over 20 Launches Coming in 2025

Rocket Lab (Nasdaq: RKLB) closed 2024 with its best year yet. The company launched more rockets, signed more contracts, and expanded deeper into spacecraft and satellite production than ever before....

US Air Force Taps Beehive to Study 3D Printed Jet Engines

Propulsion 3D printing firm Beehive Industries secured a contract from the U.S. Air Force Life Cycle Management Center through SOSSEC. SOSSEC is a company that manages Other Transactions Authority (OTA)...